13th World Congress for Neurorehabilitation 2024

13th WORLD CONGRESS FOR NEUROREHABILITATION

Initial validation of structured patient self-reports on three treatment-relevant symptoms of upper limb spastic movement disorders (UL-SMD) after stroke

Spasticity

Poster walk 3

Poster presentation

Reduction of pain in spasticity patients naïve and non-naïve to OnabotulinumtoxinA treatment: results from the aspire study

Poster walk 2

Pain in patients with spasticity: patient characteristics from the adult spasticity international registry (ASPIRE) study

Oral communications 13

Abstract talk

Learning Objectives At the end of this session, participants will be able to describe the significance of a multimodal approach to spasticity management and instructed in how to apply this approach in order to optimise outcomes for patients. CanMEDS roles Professional Target Groups Neurologists, 
Physiatrists,
Neuroscientists,
Medical Students

Accredited programme

Meeting room 3

ISPRM joint symposium

Joint symposium

Botulinumtoxin Type A for conditions other than spasticity: tremors, dystonias and paratonia

Learning Objectives At the end of this session, participants will be able to compare and contrast spasticity and other hypertonic conditions with overlapping clinical presentations. CanMEDS roles Scholar,
Professional Target Groups Neurologists,
Physiatrists,
Medical Students

Professor Jörg Wissel

Engagements

Fri, 24 May

Sat, 25 May